°Ç¸ç³Ô¹Ï

June 2026

Care Quality Commission - interim chair

Following the resignation of Professor Sir Mike Richards as chair of the Care Quality Commission (CQC) on 31 May 2026, a serving CQC non-executive director, Kay Boycott, has been appointed as interim CQC chair from 1 June until 31 July 2026, or until a new chair is able to take up appointment if one is appointed earlier.

The appointment follows consultation with the Commissioner for Public Appointments. It was made on merit and political activity played no part in the decision process. However, in accordance with the Code of Governance for Public Appointments, there is a requirement for any political activity by an appointee to be made public. Kay Boycott has not declared any political activity.

The substantive appointment of the next CQC chair will follow the government’s preferred candidate being put forward for a pre-appointment scrutiny hearing with Parliament’s Health and Social Care Committee.

The role of CQC chair requires a time commitment of 2 to 3 days per week and is remunerated at a rate of £63,000 per year.

Advisory Committee on Clinical Impact Awards - medical director 

Daniele Bryden has been appointed as the medical director of the Advisory Committee on Clinical Impact Awards (ACCIA) for 3 years from 1 July 2026.

The appointment will involve a time commitment of, on average, 2 days per week. Remuneration for the role will be at a rate of £52,540 per year.  

This appointment is made in accordance with the Cabinet Office Code of Governance for Public Appointments. The regulation of public appointments against the requirements of this code is carried out by the Commissioner for Public Appointments. 

The appointment is made on merit and political activity played no part in the decision process. However, in accordance with the code, there is a requirement for appointees’ political activity (if any declared) to be made public. Daniele has not declared any political activity.

Health Research Authority - non-executive director

Shamik Ghosh has been appointed as a non-executive director of the Health Research Authority (HRA) for 4 years from 1 June 2026.

The appointment involves a time commitment of 2 to 3 days per month. Remuneration for the role is at a rate of £7,883 per year.

This appointment is made in accordance with the Cabinet Office Code of Governance for Public Appointments. The regulation of public appointments against the requirements of this code is carried out by the Commissioner for Public Appointments. 

The appointment is made on merit and political activity played no part in the decision process. However, in accordance with the code, there is a requirement for appointees’ political activity (if any declared) to be made public. Mr Ghosh has not declared any political activity.

May 2026

Chair of Healthwatch England and Care Quality Commission non-executive directors

Professor David Croisdale-Appleby OBE has been re-appointed as Chair of Healthwatch England (HWE) and a non-executive director of the Care Quality Commission (CQC) from 1 June 2026 until 31 July 2027, or until HWE is disestablished. The appointment of both roles will continue to involve a time commitment of 2 days per week and remuneration for both roles will continue to be at a rate of £30,000 per year. 

Richard Barker CBE has been appointed as a non-executive director of CQC for 3 years from 1 April 2026. The appointment will involve a time commitment of 2 to 3 days per month and remuneration for the role will be at a rate of £7,883 per year. 

The appointments are made in accordance with the Cabinet Office Code of Governance for Public Appointments. The regulation of public appointments against the requirements of this code is carried out by the Commissioner for Public Appointments.   

The appointments are made on merit and political activity played no part in the decision process. However, in accordance with the code, there is a requirement for appointees’ political activity (if any declared) to be made public. None of the appointees have declared any political activity.

NHS Blood and Transplant - non-executive directors and Audit, Risk and Governance Committee chair

Penny McIntyre has been re-appointed as a non-executive director of NHS Blood and Transplant (NHSBT) for 3 years from 1 March 2027.  This appointment will continue to involve a time commitment of 2 to 3 days per month. Remuneration will be at a rate of £7,883 per year.

In addition, Ian Murphy has been re-appointed as a non-executive director and chair of  the NHSBT Audit, Risk and Governance Committee for 3 years from 1 March 2027. This appointment will continue to involve a time commitment of 2 to 3 days per month. Remuneration will be at a rate of £13,137 per year.

These appointments were made in accordance with the Cabinet Office Code of Governance for Public Appointments. The regulation of public appointments against the requirements of this code is carried out by the Commissioner for Public Appointments.  

The appointments are made on merit and political activity played no part in the decision process. However, in accordance with the code, there is a requirement for appointees’ political activity (if any declared) to be made public. Neither has declared any political activity.

April 2026

NHS Counter Fraud Authority - chair 

Tom Hayhoe has been appointed chair of the NHS Counter Fraud Authority (NHSCFA) for 3 years from 1 May 2026.  

The appointment will involve a time commitment of 2 to 3 days per month. Remuneration for the role will be at a rate of £14,450 per year.  

This appointment is made in accordance with the Cabinet Office Code of Governance for Public Appointments. The regulation of public appointments against the requirements of this code is carried out by the Commissioner for Public Appointments.   

The appointment is made on merit and political activity played no part in the decision process. However, in accordance with the code, there is a requirement for appointees’ political activity (if any declared) to be made public. Tom has not declared any political activity.